Daratumumab and venetoclax combined with CAGE for late R/R T-ALL/LBL patients: Single-arm, open-label, phase I study. Shi H, Yang F, Cao M, Xu T, et al. Ann Hematol 2024;103:2993-3004.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shi H, Yang F, Cao M, Xu T, et al. Daratumumab and venetoclax combined with CAGE for late R/R T-ALL/LBL patients: Single-arm, open-label, phase I study. Ann Hematol 2024;103:2993-3004.
PMID: 38662205